From: Joseph Thakuria To: Cc: Richard Kahn • Subject: Re: Jeffrey Epstein Date: Thu, 05 Jun 2014 20:36:50 +0000 OK, let's set up the call for the other topics (a and b above). We wouldn't just do his bioinformatic analyses and not the rest. le, the bioinfo platform will cost the same for 1 person vs 100 or more once the system is purchased. But I'll look into other funding for this. Obviously (and hopefully this was clear), Jeffrey's enrollment in the study has absolutely no bearing on whether he helps fund the bioinfo or not. I wouldn't do that to him. He's in regardless. As we look to fund this piece, it just seemed worth asking. Thx, Joe On Thu, Jun 5, 2014 at 4:13 PM, wrote: Hi Joe...Jeffrey says he wants to do his first and then after this, he would be happy to fund the others... On Jun 5, 2014, at 3:46 PM, Joseph Thakuria < wrote: Thanks - this is research so nothing can be 100% certain ,but, to my knowledge, our study will have greater NGS data privacy than any other similar medical genomics research effort. Afterwards, if Jeffrey still wanted to share his data through the PGP or other efforts, we could help facilitate that. Best, Joe On Thu, Jun 5, 2014 at 3:40 PM, wrote: Hi Joe! What fabulous news! I will pass this along to Jeffrey and Rich (our accountant) Hopefully Jeffrey can call you very soon-1 I'll see if I can get a possible day/time... On Jun 5, 2014, at 3:34 PM, Joseph Thakuria < > wrote: Hi Sony for the delayed response. We just got word from the IRB and we're finally ready to push forward with the YPO study. Mt I wanted to discuss a couple things with Jeffrey by phone at his convenience including: a) getting a whole genome through Illumina puts him a little bit outside of the workflow pipeline for the YPO project. le, those participants are paying $1000 each and will be getting their exomes sequenced EFTA00368480